USD 45.73
(-5.61%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 54.21 Million USD | 1.26% |
2023 | 51.82 Million USD | 9.5% |
2022 | 47.32 Million USD | 17.38% |
2021 | 40.32 Million USD | 29.54% |
2020 | 31.12 Million USD | 21.97% |
2019 | 25.52 Million USD | 28.13% |
2018 | 19.91 Million USD | 21.81% |
2017 | 16.35 Million USD | 46.69% |
2016 | 11.14 Million USD | -10.94% |
2015 | 12.51 Million USD | 6.9% |
2014 | 11.7 Million USD | 10.5% |
2013 | 10.59 Million USD | -17.37% |
2012 | 12.82 Million USD | -17.6% |
2011 | 15.56 Million USD | 8.98% |
2010 | 14.27 Million USD | -13.29% |
2009 | 16.46 Million USD | -24.01% |
2008 | 21.67 Million USD | 19.68% |
2007 | 18.1 Million USD | 1.99% |
2006 | 17.75 Million USD | 39.18% |
2005 | 12.75 Million USD | 18.17% |
2004 | 10.79 Million USD | 18.57% |
2003 | 9.1 Million USD | -8.67% |
2002 | 9.96 Million USD | -15.12% |
2001 | 11.74 Million USD | -28.49% |
2000 | 16.42 Million USD | -7.2% |
1999 | 17.69 Million USD | -22.51% |
1998 | 22.83 Million USD | -5.63% |
1997 | 24.2 Million USD | -14.49% |
1996 | 28.3 Million USD | 396.49% |
1995 | 5.7 Million USD | 1.79% |
1994 | 5.6 Million USD | 19.15% |
1993 | 4.7 Million USD | 17.5% |
1992 | 4 Million USD | 60.0% |
1991 | 2.5 Million USD | 13.64% |
1990 | 2.2 Million USD | 15.79% |
1989 | 1.9 Million USD | -20.83% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 50.54 Million USD | -1.71% |
2024 Q2 | 51.42 Million USD | 3.71% |
2024 Q1 | 49.58 Million USD | -4.32% |
2024 Q4 | 54.21 Million USD | 7.24% |
2024 FY | 54.21 Million USD | 4.61% |
2023 Q4 | 51.82 Million USD | 10.32% |
2023 Q3 | 46.97 Million USD | -1.27% |
2023 Q2 | 47.57 Million USD | -0.8% |
2023 Q1 | 47.96 Million USD | 1.35% |
2023 FY | 51.82 Million USD | 9.5% |
2022 Q2 | 42.11 Million USD | 0.59% |
2022 Q4 | 47.32 Million USD | 7.84% |
2022 FY | 47.32 Million USD | 17.38% |
2022 Q1 | 41.86 Million USD | 3.83% |
2022 Q3 | 43.88 Million USD | 4.2% |
2021 Q2 | 38.37 Million USD | 24.6% |
2021 Q1 | 30.79 Million USD | -1.06% |
2021 FY | 40.32 Million USD | 29.54% |
2021 Q4 | 40.32 Million USD | -4.71% |
2021 Q3 | 42.31 Million USD | 10.28% |
2020 Q1 | 27.97 Million USD | 9.6% |
2020 Q2 | 28.72 Million USD | 2.7% |
2020 Q3 | 28.22 Million USD | -1.73% |
2020 Q4 | 31.12 Million USD | 10.27% |
2020 FY | 31.12 Million USD | 21.97% |
2019 Q3 | 25.63 Million USD | 6.68% |
2019 FY | 25.52 Million USD | 28.13% |
2019 Q4 | 25.52 Million USD | -0.43% |
2019 Q2 | 24.02 Million USD | -4.64% |
2019 Q1 | 25.19 Million USD | 26.49% |
2018 Q3 | 19.48 Million USD | 3.56% |
2018 Q1 | 18.16 Million USD | 11.11% |
2018 FY | 19.91 Million USD | 21.81% |
2018 Q4 | 19.91 Million USD | 2.23% |
2018 Q2 | 18.81 Million USD | 3.56% |
2017 Q4 | 16.35 Million USD | 6.25% |
2017 FY | 16.35 Million USD | 46.69% |
2017 Q1 | 11.92 Million USD | 7.02% |
2017 Q2 | 15.03 Million USD | 26.03% |
2017 Q3 | 15.38 Million USD | 2.36% |
2016 FY | 11.14 Million USD | -10.94% |
2016 Q3 | 11.51 Million USD | -5.34% |
2016 Q2 | 12.16 Million USD | -0.84% |
2016 Q4 | 11.14 Million USD | -3.21% |
2016 Q1 | 12.27 Million USD | -1.97% |
2015 Q4 | 12.51 Million USD | -0.78% |
2015 FY | 12.51 Million USD | 6.9% |
2015 Q1 | 11.54 Million USD | -1.39% |
2015 Q3 | 12.61 Million USD | 5.61% |
2015 Q2 | 11.94 Million USD | 3.46% |
2014 Q3 | 10.19 Million USD | -1.92% |
2014 Q2 | 10.38 Million USD | -0.61% |
2014 FY | 11.7 Million USD | 10.5% |
2014 Q4 | 11.7 Million USD | 14.9% |
2014 Q1 | 10.45 Million USD | -1.34% |
2013 Q2 | 11.32 Million USD | -9.95% |
2013 Q4 | 10.59 Million USD | -5.83% |
2013 FY | 10.59 Million USD | -17.37% |
2013 Q1 | 12.57 Million USD | -1.95% |
2013 Q3 | 11.25 Million USD | -0.62% |
2012 Q2 | 15.3 Million USD | -0.05% |
2012 Q3 | 14.4 Million USD | -5.93% |
2012 Q4 | 12.82 Million USD | -10.96% |
2012 FY | 12.82 Million USD | -17.6% |
2012 Q1 | 15.31 Million USD | -1.58% |
2011 Q4 | 15.56 Million USD | 6.61% |
2011 Q2 | 12.73 Million USD | -5.9% |
2011 Q1 | 13.53 Million USD | -5.24% |
2011 FY | 15.56 Million USD | 8.98% |
2011 Q3 | 14.59 Million USD | 14.64% |
2010 Q3 | 17.85 Million USD | 4.75% |
2010 Q2 | 17.04 Million USD | -0.5% |
2010 Q1 | 17.12 Million USD | 4.0% |
2010 FY | 14.27 Million USD | -13.29% |
2010 Q4 | 14.27 Million USD | -20.01% |
2009 Q3 | 16.53 Million USD | -16.89% |
2009 Q2 | 19.9 Million USD | -6.11% |
2009 Q1 | 21.19 Million USD | -2.2% |
2009 FY | 16.46 Million USD | -24.01% |
2009 Q4 | 16.46 Million USD | -0.44% |
2008 Q2 | 18.63 Million USD | 2.42% |
2008 FY | 21.67 Million USD | 19.68% |
2008 Q4 | 21.67 Million USD | 8.18% |
2008 Q1 | 18.19 Million USD | 0.47% |
2008 Q3 | 20.03 Million USD | 7.51% |
2007 Q4 | 18.1 Million USD | -2.1% |
2007 FY | 18.1 Million USD | 1.99% |
2007 Q3 | 18.49 Million USD | 0.53% |
2007 Q2 | 18.39 Million USD | 4.18% |
2007 Q1 | 17.66 Million USD | -0.52% |
2006 Q1 | 12.7 Million USD | -0.41% |
2006 Q2 | 13.51 Million USD | 6.4% |
2006 FY | 17.75 Million USD | 39.18% |
2006 Q4 | 17.75 Million USD | 2.52% |
2006 Q3 | 17.31 Million USD | 28.12% |
2005 Q3 | 11.69 Million USD | 5.08% |
2005 FY | 12.75 Million USD | 18.17% |
2005 Q2 | 11.13 Million USD | 0.59% |
2005 Q1 | 11.06 Million USD | 2.5% |
2005 Q4 | 12.75 Million USD | 9.07% |
2004 Q1 | 9.79 Million USD | 7.61% |
2004 Q2 | 9.52 Million USD | -2.75% |
2004 Q3 | 9.64 Million USD | 1.2% |
2004 Q4 | 10.79 Million USD | 11.96% |
2004 FY | 10.79 Million USD | 18.57% |
2003 FY | 9.1 Million USD | -8.67% |
2003 Q4 | 9.1 Million USD | -7.17% |
2003 Q3 | 9.8 Million USD | 12.47% |
2003 Q2 | 8.72 Million USD | -2.68% |
2003 Q1 | 8.96 Million USD | -10.11% |
2002 Q1 | 11.69 Million USD | -0.44% |
2002 Q2 | 11.07 Million USD | -5.26% |
2002 Q3 | 10.57 Million USD | -4.56% |
2002 Q4 | 9.96 Million USD | -5.71% |
2002 FY | 9.96 Million USD | -15.12% |
2001 Q2 | 15.68 Million USD | -3.95% |
2001 FY | 11.74 Million USD | -28.49% |
2001 Q3 | 14.54 Million USD | -7.28% |
2001 Q4 | 11.74 Million USD | -19.25% |
2001 Q1 | 16.33 Million USD | -0.56% |
2000 Q2 | 17.7 Million USD | 2.31% |
2000 Q3 | 17 Million USD | -3.94% |
2000 Q1 | 17.3 Million USD | -2.25% |
2000 FY | 16.42 Million USD | -7.2% |
2000 Q4 | 16.42 Million USD | -3.41% |
1999 Q4 | 17.69 Million USD | -28.92% |
1999 FY | 17.69 Million USD | -22.51% |
1999 Q1 | 22.8 Million USD | -0.17% |
1999 Q2 | 22.7 Million USD | -0.44% |
1999 Q3 | 24.9 Million USD | 9.69% |
1998 Q3 | 23.1 Million USD | -0.86% |
1998 Q4 | 22.83 Million USD | -1.13% |
1998 Q2 | 23.3 Million USD | -2.51% |
1998 Q1 | 23.9 Million USD | -1.24% |
1998 FY | 22.83 Million USD | -5.63% |
1997 Q2 | 29.1 Million USD | 2.11% |
1997 Q4 | 24.2 Million USD | -13.57% |
1997 Q3 | 28 Million USD | -3.78% |
1997 FY | 24.2 Million USD | -14.49% |
1997 Q1 | 28.5 Million USD | 0.71% |
1996 FY | 28.3 Million USD | 396.49% |
1996 Q3 | 25.3 Million USD | 4.12% |
1996 Q1 | 24.5 Million USD | 329.82% |
1996 Q2 | 24.3 Million USD | -0.82% |
1996 Q4 | 28.3 Million USD | 11.86% |
1995 Q2 | 5.9 Million USD | 3.51% |
1995 Q3 | 6 Million USD | 1.69% |
1995 Q4 | 5.7 Million USD | -5.0% |
1995 FY | 5.7 Million USD | 1.79% |
1995 Q1 | 5.7 Million USD | 1.79% |
1994 Q3 | 5.3 Million USD | 3.92% |
1994 Q4 | 5.6 Million USD | 5.66% |
1994 Q2 | 5.1 Million USD | 4.08% |
1994 FY | 5.6 Million USD | 19.15% |
1994 Q1 | 4.9 Million USD | 4.26% |
1993 FY | 4.7 Million USD | 17.5% |
1993 Q4 | 4.7 Million USD | 9.3% |
1993 Q3 | 4.3 Million USD | 4.88% |
1993 Q2 | 4.1 Million USD | 0.0% |
1993 Q1 | 4.1 Million USD | 2.5% |
1992 FY | 4 Million USD | 60.0% |
1992 Q3 | 3.4 Million USD | 0.0% |
1992 Q4 | 4 Million USD | 17.65% |
1991 Q4 | 2.5 Million USD | 0.0% |
1991 FY | 2.5 Million USD | 13.64% |
1990 Q4 | 2.2 Million USD | 0.0% |
1990 FY | 2.2 Million USD | 15.79% |
1989 FY | 1.9 Million USD | -20.83% |
1989 Q4 | 1.9 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Akoya Biosciences, Inc. | 180.36 Million USD | 69.945% |
AngioDynamics, Inc. | 317.67 Million USD | 82.935% |
AtriCure, Inc. | 613.93 Million USD | 91.17% |
Avinger, Inc. | 13.77 Million USD | -293.682% |
Azenta, Inc. | 2.88 Billion USD | 98.121% |
BioLife Solutions, Inc. | 412.71 Million USD | 86.865% |
The Cooper Companies, Inc. | 11.65 Billion USD | 99.535% |
Daxor Corporation | 34.86 Million USD | -55.467% |
Ekso Bionics Holdings, Inc. | 28.91 Million USD | -87.461% |
Femasys Inc. | 27.75 Million USD | -95.31% |
GlucoTrack, Inc. | 4.9 Million USD | -1005.199% |
Harvard Bioscience, Inc. | 137.36 Million USD | 60.536% |
Hologic, Inc. | 9.15 Billion USD | 99.408% |
ICU Medical, Inc. | 4.37 Billion USD | 98.762% |
Intuitive Surgical, Inc. | 15.44 Billion USD | 99.649% |
KORU Medical Systems, Inc. | 28.46 Million USD | -90.471% |
LeMaitre Vascular, Inc. | 346.77 Million USD | 84.368% |
Innovative Eyewear, Inc. | 6.21 Million USD | -771.717% |
Innovative Eyewear, Inc. | 6.21 Million USD | -771.717% |
Masimo Corporation | 3.04 Billion USD | 98.218% |
Microbot Medical Inc. | 8.32 Million USD | -551.015% |
Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 68.467% |
Merit Medical Systems, Inc. | 2.32 Billion USD | 97.669% |
Nephros, Inc. | 11.86 Million USD | -357.044% |
NovoCure Limited | 1.14 Billion USD | 95.27% |
NEXGEL, Inc. | 9.95 Million USD | -444.55% |
NEXGEL, Inc. | 9.95 Million USD | -444.55% |
Singular Genomics Systems, Inc. | 265.46 Million USD | 79.579% |
OraSure Technologies, Inc. | 482.84 Million USD | 88.773% |
Pulse Biosciences, Inc. | 60.8 Million USD | 10.845% |
Predictive Oncology Inc. | 14.41 Million USD | -276.008% |
Precision Optics Corporation, Inc. | 16.91 Million USD | -220.531% |
QuidelOrtho Corporation | 8.56 Billion USD | 99.367% |
Repligen Corporation | 2.82 Billion USD | 98.081% |
Sanara MedTech Inc. | 73.87 Million USD | 26.615% |
STAAR Surgical Company | 488.69 Million USD | 88.907% |
Sharps Technology, Inc. | 11.78 Million USD | -359.825% |
Utah Medical Products, Inc. | 135.45 Million USD | 59.98% |
DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.264% |
Jin Medical International Ltd. | 32.9 Million USD | -64.755% |